Department of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan.
Int J Mol Sci. 2022 Aug 20;23(16):9409. doi: 10.3390/ijms23169409.
Polyploidy, a condition in which more than two sets of chromosomes are present in a cell, is a characteristic feature of hepatocytes. A significant number of hepatocytes physiologically undergo polyploidization at a young age. Polyploidization of hepatocytes is enhanced with age and in a diseased liver. It is worth noting that polyploid hepatocytes can proliferate, in marked contrast to other types of polyploid cells, such as megakaryocytes and cardiac myocytes. Polyploid hepatocytes divide to maintain normal liver homeostasis and play a role in the regeneration of the damaged liver. Furthermore, polyploid hepatocytes have been shown to dynamically reduce ploidy during liver regeneration. Although it is still unclear why hepatocytes undergo polyploidization, accumulating evidence has revealed that alterations in the ploidy in hepatocytes are involved in the pathophysiology of liver cirrhosis and carcinogenesis. This review discusses the significance of hepatocyte ploidy in physiological liver function, liver injury, and liver cancer.
多倍体,即一个细胞中存在两套以上染色体的情况,是肝细胞的一个特征。大量的肝细胞在年轻时会经历多倍体化。随着年龄的增长和肝脏疾病的发生,肝细胞的多倍体化会增强。值得注意的是,与其他类型的多倍体细胞(如巨核细胞和心肌细胞)相比,多倍体肝细胞可以增殖。多倍体肝细胞通过分裂来维持正常的肝脏内稳态,并在受损肝脏的再生中发挥作用。此外,多倍体肝细胞在肝脏再生过程中表现出动态的倍性降低。尽管尚不清楚为什么肝细胞会发生多倍体化,但越来越多的证据表明,肝细胞倍性的改变与肝硬化和肝癌的病理生理学有关。这篇综述讨论了肝细胞倍性在生理肝功能、肝损伤和肝癌中的意义。